Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
cabotegravir 30 mg tablet |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
1787381759 |
cabotegravir 30 mg tablet |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
1787381759 |
cabotegravir |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
1034051765 |
Vocabria 30 mg tablet |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
1728980337 |
Vocabria 30 mg tablet |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
1728980337 |
cabotegravir 600 mg/3 mL modified release injection, vial |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
1418464647 |
cabotegravir 600 mg/3 mL modified release injection, vial |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
1418464647 |
Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
1612915855 |
Cabenuva Cabotegravir 600 mg/3 mL modified release injection, 3 mL vial |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
1612915855 |
cabotegravir 400 mg/2 mL modified release injection, vial |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
570830329 |
cabotegravir 400 mg/2 mL modified release injection, vial |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
570830329 |
Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
1760701123 |
Cabenuva Cabotegravir 400 mg/2 mL modified release injection, 2 mL vial |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
1760701123 |
Apretude 600 mg/3 mL modified release injection, 3 mL vial |
has Australian BoSS |
True |
cabotegravir |
Inferred relationship |
Some |
948172413 |
Apretude 600 mg/3 mL modified release injection, 3 mL vial |
has intended active ingredient |
True |
cabotegravir |
Inferred relationship |
Some |
948172413 |